1. Home
  2. GASS vs LCTX Comparison

GASS vs LCTX Comparison

Compare GASS & LCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GASS

StealthGas Inc.

HOLD

Current Price

$9.11

Market Cap

345.6M

ML Signal

HOLD

Logo Lineage Cell Therapeutics Inc.

LCTX

Lineage Cell Therapeutics Inc.

HOLD

Current Price

$1.46

Market Cap

407.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GASS
LCTX
Founded
2004
1990
Country
Greece
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
345.6M
407.7M
IPO Year
2005
1996

Fundamental Metrics

Financial Performance
Metric
GASS
LCTX
Price
$9.11
$1.46
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$6.00
AVG Volume (30 Days)
242.8K
1.1M
Earning Date
03-02-2026
03-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$14,556,000.00
Revenue This Year
N/A
$55.75
Revenue Next Year
N/A
$2.96
P/E Ratio
$5.00
N/A
Revenue Growth
N/A
53.24
52 Week Low
$4.90
$0.37
52 Week High
$10.52
$2.09

Technical Indicators

Market Signals
Indicator
GASS
LCTX
Relative Strength Index (RSI) 52.03 32.08
Support Level $8.67 $0.94
Resistance Level $10.52 $1.84
Average True Range (ATR) 0.46 0.11
MACD -0.08 -0.04
Stochastic Oscillator 29.19 1.85

Price Performance

Historical Comparison
GASS
LCTX

About GASS StealthGas Inc.

StealthGas Inc is an international shipping transportation company. It owns liquefied petroleum gas (LPG) pressurized carriers and provides international seaborne transportation services to LPG producers and users, as well as crude oil and product carriers to oil producers, refineries, and commodities traders. The company carriers carry various petroleum gas products in liquefied forms, such as propane, butane, butadiene, isopropane, propylene, and vinyl chloride monomer, which are all byproducts of the production of crude oil and natural gas.

About LCTX Lineage Cell Therapeutics Inc.

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline is based on two platform technologies including cell replacement and cell/drug delivery. Lineage Cell's product candidate is OpRegen, a retinal pigment epithelium transplant therapy for the treatment of dry age-related macular degeneration, OPC1, an oligodendrocyte progenitor cell therapy for acute spinal cord injuries, and VAC2, allogeneic cancer immunotherapy of antigen-presenting dendritic cells for non-small cell lung cancer, ANP1, an allogeneic auditory neuron progenitor cells transplant for hearing loss, and PNC1, an allogeneic photoreceptor cell transplant for vision loss.

Share on Social Networks: